Physician profile
Gloria B Chu
NPI 1497983423
$5,922.61
in general payments reported to CMS, 2019-2025
27 companies · $686 in 2025
The $686 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,066 · 2020: $12.95 · 2021: $146 · 2022: $1,326 · 2023: $2,099 · 2024: $586 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,223 · Travel and Lodging: $1,132 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,222.92 |
| Travel and Lodging | $1,132.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,700.55 | 2020-2023 | Da Vinci Surgical System, Da Vinci Sp |
| W. L. Gore & Associates, INC. | $1,140.32 | 2019-2025 | Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Medtronic, INC. | $858.73 | 2022-2025 | Signia, Minimed 780g |
| Pfizer INC. | $232.81 | 2019 | |
| Boston Scientific Corporation | $149.02 | 2025 | Spyglass Discover |
| Bausch & Lomb Americas INC. | $133.18 | 2024 | Xiidra, Miebo |
| Smith+Nephew, INC. | $105.03 | 2024-2025 | Grafix Pl, Grafix |
| Innovation Technologies INC | $86.91 | 2025 | Irrisept |
| Lilly USA, LLC | $62.56 | 2023-2024 | Zepbound |
| Zimmer Biomet Holdings, INC. | $51.43 | 2024 | Avenir |
| Integra Lifesciences Corporation | $35.63 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Corcept Therapeutics | $34.62 | 2022-2023 | Korlym |
| Ethicon US, LLC | $28.58 | 2024 | Enseal X1, Echelon Flex |
| Solventum Corporation | $26.61 | 2025 | Activ.A.C. |
| Humacyte Global, INC. | $26.18 | 2025 | Symvess |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Standard Bariatrics, INC. | $25.22 | 2022 | |
| Intra-Sana Laboratories | $23.72 | 2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Organogenesis INC. | $22.70 | 2022 | |
| Xeris Pharmaceuticals, INC. | $22.12 | 2022 | |
| Advanced Oxygen Therapy INC. | $21.95 | 2024 | Topical Oxygen Chamber For Extremities |
| Celgene Corporation | $21.15 | 2019 | |
| Tandem Diabetes Care, INC. | $20.70 | 2022 | |
| Tela Bio, INC. | $20.50 | 2024 | Ovitex 2s |
| Sanofi-Aventis U.S. LLC | $20.04 | 2023 | |
| Portola Pharmaceuticals, LLC | $19.58 | 2019 | |
| Dexcom, INC. | $17.09 | 2023 | Dexcom G6 Transmitter |
| Amneal Pharmaceuticals LLC | $15.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gloria Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.